Long COVID develops because of a combination of biological processes that go wrong during or after a SARS-CoV-2 infection, and certain people are more vulnerable to these processes than others. As of 2023, about 6.4% of U.S. adults were experiencing long COVID at any given time, yet most people who catch COVID recover fully. The difference comes down to a handful of overlapping mechanisms, from leftover virus hiding in tissues to an immune system that turns on the body itself, layered on top of individual risk factors like genetics, sex, weight, and pre-existing health conditions.
Leftover Virus That Never Fully Clears
One of the strongest explanations is that fragments of SARS-CoV-2, or even active virus, persist in various organs long after the initial infection resolves. Viral RNA or viral proteins (particularly the spike protein and nucleoprotein) have been found in the lungs, liver, gallbladder, lymph nodes, skin, and throughout the gastrointestinal tract, including the colon, small bowel, and gut lining. In the brain, spike protein has been detected persisting for up to 12 months in the skull-meninges-brain axis, and viral RNA has been found throughout brain tissue as far out as 230 days after symptoms first appeared. Viral material has also turned up in tonsils, adenoids, and even the taste buds on the tongue.
These viral reservoirs appear to act as a continuous irritant, keeping the immune system in a state of low-grade activation. The result is chronic inflammation that can affect whichever organs harbor the remnants. This helps explain why long COVID symptoms vary so widely from person to person: the specific tissues where the virus lingers may determine whether someone develops brain fog, digestive problems, chest pain, or fatigue.
The Immune System Attacking the Body
In some people, the immune response to COVID-19 goes off the rails and starts producing antibodies that target the body’s own tissues. A study of 31 long COVID patients found that every single one had between two and seven different types of these self-targeting antibodies. These antibodies latch onto receptors that regulate heart rate, blood pressure, pain signaling, and blood vessel function. Some speed up heart cells, others slow them down, creating the kind of contradictory signals that could explain symptoms like heart palpitations, dizziness, and exercise intolerance.
This autoimmune-like response may be triggered by molecular mimicry, where viral proteins resemble the body’s own proteins closely enough that the immune system gets confused. Once these autoantibodies are produced, they can persist for months, continuing to interfere with normal cell signaling well after the virus itself is gone.
Reactivation of Dormant Viruses
Most adults carry latent viruses picked up earlier in life, particularly Epstein-Barr virus (the virus that causes mono), which lies dormant in about 95% of the global population. COVID-19 appears to wake these viruses back up. In one study, 50% of long COVID patients had detectable Epstein-Barr virus DNA in their throats, compared to only 20% of people who recovered from COVID without lingering symptoms. Blood tests confirmed these weren’t new infections but reactivations of old ones.
This reactivation likely happens because SARS-CoV-2 disrupts the immune surveillance that normally keeps latent viruses in check. The reawakened viruses then pile additional inflammation and fatigue on top of whatever damage COVID itself caused.
Tiny Blood Clots That Starve Tissues of Oxygen
A distinctive feature of long COVID is the formation of abnormal, densely packed microclots in the blood. These aren’t typical blood clots. They’re made of fibrin (the protein that normally forms a mesh to stop bleeding) tangled into tough, amyloid-like structures that resist the body’s normal clot-dissolving processes. These microclots are small enough to lodge in capillaries, the tiniest blood vessels where oxygen passes from blood into tissues.
When capillaries get blocked, the tissues downstream are starved of oxygen. This single mechanism can plausibly explain many of long COVID’s hallmark symptoms: breathlessness from poor oxygen exchange in the lungs, brain fog from reduced oxygen delivery to the brain, fatigue from muscles that can’t get enough fuel, and even chest pain and heart problems. The microclots also trap inflammatory molecules inside them, creating pockets of inflammation that the body struggles to clear.
Nerve Damage and Autonomic Dysfunction
The vagus nerve, the longest nerve in the body, runs from the brainstem down through the neck and into the chest and abdomen. It controls heart rate, digestion, breathing rhythm, and dozens of other automatic functions you never think about. Postmortem studies of COVID-19 patients have found SARS-CoV-2 RNA inside the vagus nerve along with significant infiltration of immune cells, primarily monocytes, indicating active inflammation.
When the vagus nerve is inflamed, the body’s autonomic “autopilot” malfunctions. This can cause a racing heart upon standing, digestive problems, difficulty regulating blood pressure, and a general sense that the body can’t maintain its basic equilibrium. This type of dysfunction, called dysautonomia, is one of the most commonly reported features of long COVID and may persist as long as the nerve inflammation continues.
Gut Bacteria Thrown Out of Balance
COVID-19 significantly disrupts the gut microbiome, and these changes persist long after the acute infection. Studies following patients for up to six months after recovery have found sustained reductions in microbial diversity. Specifically, beneficial anti-inflammatory bacteria like Faecalibacterium prausnitzii and Bifidobacterium adolescentis are suppressed, while harmful species flourish. This imbalance correlates with higher levels of C-reactive protein, a marker of systemic inflammation.
Since the gut microbiome plays a central role in regulating immune function, this disruption may feed back into the other mechanisms, keeping immune activation elevated and making it harder for the body to resolve inflammation and return to baseline.
Who Is Most at Risk
Not everyone faces equal odds. A large Scottish study using national health records found several clear patterns. Women make up about 65% of long COVID cases despite being roughly 50% of the population. People between ages 38 and 67 are disproportionately affected. Being overweight or obese nearly doubles the proportion at risk (45.7% of long COVID patients versus 29.4% of the general population). And having one or more pre-existing health conditions raises vulnerability significantly, with 52.7% of long COVID patients having at least one comorbidity compared to 36% of the general population.
These risk factors likely interact with the biological mechanisms above. Higher body weight is associated with greater baseline inflammation. Pre-existing conditions may mean the immune system is already slightly dysregulated before COVID hits. The sex difference may relate to hormonal influences on immune function, since women generally mount stronger immune responses, which is protective against severe acute infection but may increase the risk of autoimmune-like complications afterward.
Genetics Play a Role
A large genome-wide association study published in Nature Genetics identified genetic variants near the FOXP4 gene that are associated with long COVID risk. FOXP4 is a transcription factor active in lung tissue, and the same variants have been previously linked to both lung cancer and COVID-19 severity. The association was particularly strong in people who were unvaccinated and those infected with earlier strains of the virus. The broader finding from this research is that long COVID, like other post-viral conditions, is a genetically heterogeneous disease, meaning multiple genes contribute small amounts of risk rather than a single gene determining the outcome.
Vaccination Offers Partial Protection
Getting vaccinated before infection reduces long COVID risk, though the protection requires multiple doses. Studies have found that three or more vaccine doses lower the probability of developing long COVID symptoms by about 30%. For neurological symptoms specifically, the protection is slightly higher at 39%. One or two doses alone did not show a significant protective effect against long COVID in these analyses. The mechanism likely involves priming the immune system to clear the virus more quickly and completely, reducing the chance of viral persistence and the downstream cascade of inflammation, autoimmunity, and clotting that follows.
Why It All Varies So Much
The reason long COVID looks so different from person to person is that it’s not one disease. It’s the end result of whichever combination of these mechanisms takes hold in a given individual. Someone with viral persistence in brain tissue and vagus nerve inflammation will experience cognitive problems and autonomic dysfunction. Someone whose primary issue is microclots may struggle mainly with fatigue and breathlessness. Someone with autoantibody production might develop heart palpitations and blood pressure instability. And these mechanisms overlap: viral persistence can drive autoimmunity, which worsens inflammation, which promotes clotting, which reduces oxygen delivery, which compounds fatigue.
This layered, interconnected biology is why long COVID has been so difficult to define, diagnose, and treat. It also explains why the same infection can leave one person bedridden for months while the person who infected them feels fine within a week. The virus is the trigger, but the body’s unique response, shaped by genetics, sex, immune history, weight, gut health, and prior conditions, determines what happens next.